Effects of influenza immunization on humoral and cellular alloreactivity in humans

Transplantation

Volumn 89, Issue 7, 2010, Pages 838-844

  Danziger Isakov, Lara ^a   Cherkassky, Leonid ^a   Siegel, Hanni ^a   McManamon, Mary ^a   Kramer, Kristen ^a   Budev, Marie ^a   Sawinski, Deirdre ^b   Augustine, Joshua J ^c   Hricik, Donald E ^c   Fairchild, Robert ^a   Heeger, Peter S ^b   Poggio, Emilio D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Allosensitization; Heterologous immunity; Influenza; T cell; Vaccination

Indexed keywords

ALLOANTIBODY; CALCINEURIN INHIBITOR; GAMMA INTERFERON; HLA ANTIBODY; INFLUENZA VACCINE; PREDNISONE;

ADULT; ALLOIMMUNITY; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; BLOOD SAMPLING; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG POTENCY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FLOW CYTOMETRY; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOREACTIVITY; INFLUENZA VACCINATION; KIDNEY GRAFT; LONG TERM CARE; LUNG TRANSPLANTATION; MALE; PRIORITY JOURNAL;

ADULT; ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HLA ANTIGENS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNIZATION; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INTERFERON-GAMMA; ISOANTIBODIES; KIDNEY TRANSPLANTATION; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; T-LYMPHOCYTES; TIME FACTORS;

EID: 77950960633     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181ca56f8     Document Type: Article

References (40)

1. Heeger PS. T-cell allorecognition and transplant rejection: A summary and update. Am J Transplant 2003; 3: 525.
2. Heeger PS, Greenspan NS, Kuhlenschmidt S, et al. Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J Immunol 1999; 163: 2267.
3. Valujskikh A. Memory T cells in allograft rejection. Adv Exp Med Biol 2007; 601: 247.
4. Valujskikh A, Li XC. Frontiers in nephrology: T cell memory as a barrier to transplant tolerance. J Am Soc Nephrol 2007; 18: 2252.
5. Augustine JJ, Poggio ED, Clemente M, et al. Hemodialysis vintage, black ethnicity, and pretransplantation antidonor cellular immunity in kidney transplant recipients. J Am Soc Nephrol 2007; 18: 1602.
6. Augustine JJ, Siu DS, Clemente MJ, et al. Pre-transplant IFN-gamma ELISPOTs are associated with post-transplant renal functionin African American renal transplant recipients. Am J Transplant 2005; 5: 1971.
7. Adams AB, Williams MA, Jones TR, et al. Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 2003; 111: 1887.
8. Adams AB, Pearson TC, Larsen CP. Heterologous immunity: An overlooked barrier to tolerance. Immunol Rev 2003; 196: 147.
9. Taylor DK, NeujahrD,Turka LA. Heterologous immunity and homeo-static proliferation as barriers to tolerance. Curr Opin Immunol 2004; 16: 558.
10. Alegre ML, Leemans J, Le Moine A, et al. The multiple facets of toll-like receptors in transplantation biology. Transplantation 2008; 86: 1.
11. Chen L, Wang T, Zhou P, et al. TLR engagement prevents transplantation tolerance. Am J Transplant 2006; 6: 2282.
12. Porrett PM, Yuan X, LaRosa DF, et al. Mechanisms underlying blockade of allograft acceptance by TLR ligands. J Immunol 2008; 181: 1692.
13. Meier-Kriesche HU, Schold JD, Kaplan B. Long-term renal allograft survival: Have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant 2004; 4: 1289.
14. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA 2004; 292: 1333.
15. Vilchez RA, McCurry K, Dauber J, et al. Influenza virus infection in adult solid organ transplant recipients. Am J Transplant 2002; 2: 287.
16. Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant 2004; 4(suppl 10): 160.
17. Avery RK, Michaels M. Update on immunizations in solid organ transplant recipients: What clinicians need to know. Am J Transplant 2008; 8: 9.
18. Mazzone PJ, Mossad SB, Mawhorter SD, et al. Cell-mediated immune response to influenza vaccination in lung transplant recipients. J Heart Lung Transplant 2004; 23: 1175.
19. Mazzone PJ, Mossad SB, Mawhorter SD, et al. The humoral immune response to influenza vaccination in lung transplant patients. Eur Re-spirJ2001; 18: 971.
20. Magnani G, Falchetti E, Pollini G, et al. Safety and efficacy of two types of influenza vaccination in heart transplant recipients: A prospective randomised controlled study. J Heart Lung Transplant 2005; 24: 588.
21. Lawal A, Basler C, Branch A, et al. Influenza vaccination in orthotopic liver transplant recipients: Absence of post administration ALT elevation. Am J Transplant 2004; 4: 1805.
22. Scharpe J, Evenepoel P, Maes B, et al. Influenza vaccination is efficacious and safe in renal transplant recipients. Am J Transplant 2008; 8: 332.
23. White-Williams C, Brown R, Kirklin J, et al. Improving clinical practice: Should we give influenza vaccinations to heart transplant patients? J Heart Lung Transplant 2006; 25: 320.
24. Poggio ED, Clemente M, Riley J, et al. Alloreactivity in renal transplant recipients with and without chronic allograft nephropathy. J Am Soc Nephrol 2004; 15: 1952.
25. Poggio ED, Roddy M, Riley J, et al. Analysis of immune markers in human cardiac allograft recipients and association with coronary artery vasculopathy. J Heart Lung Transplant 2005; 24: 1606.
26. Gebauer BS, Hricik DE, Atallah A, et al. Evolution of the enzyme-linked immunosorbent spot assay for post-transplant alloreactivity as a potentially useful immune monitoring tool. Am J Transplant 2002; 2: 857.
27. Hricik DE, Rodriguez V, Riley J, et al. Enzyme linked immunosorbent spot (ELISPOT) assay for interferon-gamma independently predicts renal function in kidney transplant recipients. Am J Transplant 2003; 3: 878.
28. Poggio ED, Augustine JJ, Clemente M, et al. Pretransplant cellular al-loimmunity as assessed by a panel of reactive T cells assay correlates with acute renal graft rejection. Transplantation 2007; 83: 847.
29. Poggio ED, Clemente M, Hricik DE, et al. Panel of reactive T cells as a measurement of primed cellular alloimmunity in kidney transplant candidates. J Am Soc Nephrol 2006; 17: 564.
30. Beyer WE, Palache AM, Luchters G, et al. Seroprotection rate, mean fold increase, seroconversion rate: Which parameter adequately expresses seroresponse to influenza vaccination? Virus Res 2004; 103:125.
31. Briggs JD, Timbury MC, Paton AM, et al. Viral infection and renal transplant rejection. BMJ1972; 4: 520.
32. Briggs WA, Rozek RJ, Migdal SD, et al. Influenza vaccination in kidney transplant recipients: Cellular and humoral immune responses. Ann Intern Med 1980; 92: 471.
33. Lopez C, Simmons RL, Mauer SM, et al. Association of renal allograft rejection with virus infections. Am J Med 1974; 56: 280.
34. Gabriel R, Selwyn S, Brown D, et al. Virus infections and acute renal transplant rejection. Nephron 1976; 16: 282.
35. Grekas D, Alivanis P, Kiriazopoulou V, et al. Influenza vaccination on renal transplant patients is safe and serologically effective. Int J Clin Pharmacol Ther Toxicol 1993; 31: 553.
36. Kobashigawa JA, Warner-Stevenson L, Johnson BL, et al. Influenza vaccine does not cause rejection after cardiac transplantation. Transplant Proc 1993; 25: 2738.
37. Avery RK. Cardiac-allograft vasculopathy. NEngl JMed 2003; 349:829.
38. Avery RK. Viral triggers of cardiac-allograft dysfunction. NEngl JMed 2001; 344: 1545.
39. Pantenburg B, Heinzel F, Das L, et al. T cells primed by Leishmania major infection cross-react with alloantigens and alter the course of allograft rejection. J Immunol 2002; 169: 3686.
40. + T cells in heterologous antiviral immunity and immunopathology in the lung. Nat Immunol 2001; 2: 1067.